News Delix Therapeutics to start clinical trial on novel psychoplastogen drug DLX-001 is a non-hallucinogenic compound intended to treat various mental health conditions Rowan DunneMay 9, 2023
Technology Rendever acquires Alcove to extend VR social networking for seniors The goal is to amplify human connections through an integrated platform Natalia Buendia CalvilloJanuary 6, 2023
Cannabis Delix gets recognized as leading start-up by Nature Biotechnology Renowned academic journal praises company for development of psychoplastogens Rowan DunneSeptember 14, 2022
Canada Massachusetts’ cannabis sales worth over half of entire Canadian market The Bay State and its 6.9 million residents have averaged $45 million in monthly legal weed sales since November 2018 Jared GnamFebruary 4, 2020